Inission (INISS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 sales declined 9.1% to SEK 468 million, with organic sales down 16% and AXXE contributing 33 MSEK; order intake increased by 6 MSEK to 464 MSEK.
EBIT for Q3 was SEK 25.8 million (down from 44.3 million), with EPS at 0.6 SEK (1.4 SEK); EBIT margin was 5.5% (8.6%).
LTM sales just below SEK 2.2 billion, with EBIT margin at 6.2% versus 7.2% last year.
Inventory value reduced by 29 MSEK in Q3 and by 130 MSEK since Q3 last year (excluding AXXE).
Cost reduction initiatives are ongoing, with personnel costs lower and further cuts expected in Q1 and Q2 next year.
Financial highlights
Gross margin for Q3 improved to 27.5% (26.7%) due to stabilized material prices and price increases.
EBITDA margin for Q3 was 10.5% (12.2%), with full-year group margin expected above 6%, revised down from 7%.
Cash flow from operations for Q3 was -39.5 MSEK (7.8 MSEK), impacted by cessation of factoring and early COVID loan repayment, totaling SEK 160 million in negative effects year-to-date.
Net debt at period end was -526 MSEK (-538 MSEK), with equity ratio at 37.8% (36.2%).
Net income for Q3 was 13.2 MSEK (27.9 MSEK); for Jan–Sep, 64.4 MSEK (82.3 MSEK).
Outlook and guidance
Full-year sales target revised to SEK 2.1–2.2 billion from SEK 2.4 billion due to market slowdown.
EBITA margin target for 2024 revised from 7% to 6%; mid-term targets for 15% annual growth and 9% EBITDA margin remain unchanged.
Management expects the downturn to bottom out in Q4, with growth resuming in H2 2025.
Cost base expected to align with lower demand by Q1–Q2 next year.
Latest events from Inission
- 2025 revenue rose to SEK 2,206.2 million, with strong cash flow and positive 2026 outlook.INISS
Q4 202520 Feb 2026 - Q2 sales up 1.4% to 570 MSEK, but organic growth and margins declined.INISS
Q2 202423 Jan 2026 - Revised targets and integration efforts position the company for renewed growth next year.INISS
ABGSC Investor Days11 Jan 2026 - Sales and margins fell, but order intake and cash flow rebounded; cost cuts and recovery expected.INISS
Q4 202426 Dec 2025 - Targeting 15% annual growth and 9% EBITDA margin, leveraging acquisitions and mega trends.INISS
CMD 202529 Nov 2025 - Order intake up, sales and profit down; cost cuts and Nasdaq listing shape cautious outlook.INISS
Q1 & AGM 202526 Nov 2025 - Sales fell 6.2%, but order intake, cash flow, and acquisitions signal H2 recovery.INISS
Q2 202523 Nov 2025 - Q3 sales and margins improved, EMS strong, Enedo restructuring, 2025 targets revised.INISS
Q3 20257 Nov 2025